Scarica l'app Stockscreener
18.56
6.06%
1.06
Dopo l'orario di chiusura:
18.56
Upstream Bio Inc Borsa (UPB) Ultime notizie
Ichimoku Cloud Indicates Uncertainty Around Upstream Bio Inc.July 2025 Volume & Reliable Entry Point Alerts - 선데이타임즈
Short interest data insights for Upstream Bio Inc.Quarterly Trade Review & AI Based Buy and Sell Signals - Newser
Upstream Bio Inc. stock momentum explained [Market Growth Review]Weekly Sector Rotation Insights - Newser
Analyzing recovery setups for Upstream Bio Inc. investorsTrade Volume Summary & Daily Stock Trend Watchlist - Newser
Upstream Bio Appoints Stacy Price as Chief Technology Officer - The Globe and Mail
Tools to assess Upstream Bio Inc.’s risk profileFree Community Entry Consensus Trade Ideas - Newser
Real time social sentiment graph for Upstream Bio Inc.Risk Adjusted Trade Signal Screening Tool - Newser
Upstream Bio Inc. stock retracement – recovery analysisFree Reliable Chart-Based Trade Entries - Newser
Comparing Upstream Bio Inc. in custom built stock radarsFree Short Term Buy Zone Stock Alerts - Newser
Real time breakdown of Upstream Bio Inc. stock performanceFree Chart Alert System With Entry Targets - Newser
Analyzing net buyer seller activity in Upstream Bio Inc.Free Conservative Long Term Growth Plans - Newser
Building trade automation scripts for Upstream Bio Inc.Free Real Time Trade Opportunity Alerts - Newser
What makes Upstream Bio Inc. stock price move sharplyForecasting Stock Moves with AI Insights - Newser
How Efficient Is Upstream Bio Inc. at Controlling Operating CostsChart Signal and Short-Term Forecast Tracker - Newser
Upstream Bio Inc. stock momentum explainedFree Investment Strategy With Predictable Gains - Newser
Upstream Bio Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingMachine Learning Intraday Signal Forecast - Newser
Tools to monitor Upstream Bio Inc. recovery probabilityHigh Reward Picks with Tight Risk Control - Newser
Q3 EPS Estimates for Upstream Bio Decreased by William Blair - Defense World
Upstream Bio Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
How to manage a losing position in Upstream Bio Inc.Free Expert Verified Stock Trade Ideas - Newser
How to use a screener to detect Upstream Bio Inc. breakoutsFree Day Trading Signals With High Precision - Newser
Upstream Bio 2025 Q2 Earnings Net Loss Widens Despite Revenue Surge - AInvest
Upstream Bio, Inc. Reports Increased R&D Investments - TipRanks
Upstream Bio (UPB) Q2 R&D Soars 169% - The Globe and Mail
Is it too late to sell Upstream Bio Inc.Low Risk Strategy with Smart Entry Zones - Newser
Key resistance and support levels for Upstream Bio Inc.Free Swing Trade With Risk Management - Newser
Positive Outlook for Upstream Bio, Inc. Driven by Promising Clinical Trial Developments - TipRanks
Optimistic Buy Rating for Upstream Bio, Inc. Driven by Promising Lead Asset and Strong Execution - TipRanks
Upstream Bio's Q2 2025: Can a Robust Cash Position and TSLP Pipeline Sustain Investor Optimism Amid Rising Burn Rates? - AInvest
Upstream Bio Q2 Net Loss Narrows, Revenue Rises - MarketScreener
Upstream Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Upstream Bio's Strategic Momentum in TSLP Inhibition: A Pathway to Redefining Respiratory Disease Treatment? - AInvest
Earnings Flash (UPB) Upstream Bio Posts Q2 Net Loss $0.74 a Share, vs. FactSet Est of $0.61 Loss - MarketScreener
Upstream Bio reports Q2 revenue $937k, consensus $317k - TipRanks
Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress - GlobeNewswire
Upstream Bio Advances 3 Phase 2 Trials for Novel Respiratory Drug, Q3 Data Readout Imminent - Stock Titan
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):